Best Biotechnology Stocks

Compare the best biotech stocks to buy today.

Biotech stocks are investments in companies that develop products and technologies based on biological research, primarily aimed at advancing healthcare, agriculture, and environmental solutions. These stocks are known for their potential for high growth but also come with significant volatility due to the complex nature of biotechnological development and regulatory environments.

This list includes the largest market-cap stocks in the biotechnology field. View each stock's current price, PE ratio, volume, and recent indicators of potential movement.

On This Page: Biotech Stock Resources FAQ Why Invest in Biotech Stocks

Company	Current Price	PE Ratio	Market Cap	Volume	Average Volume	Indicator(s)
ABBV AbbVie	$180.00 +0.9%	62.50	$318.09 billion	2.69 million	5.60 million
TMO Thermo Fisher Scientific	$528.98 +0.7%	33.16	$202.33 billion	488,699	1.55 million	Analyst Forecast
DHR Danaher	$230.75 +0.7%	44.04	$166.66 billion	988,300	2.82 million	Analyst Forecast
VRTX Vertex Pharmaceuticals	$408.18 +0.7%	N/A	$105.12 billion	1.47 million	1.24 million	Analyst Forecast Analyst Revision
GSK GSK	$34.03 -0.1%	22.10	$70.53 billion	1.38 million	4.15 million
COR Cencora	$227.54 0.0%	30.30	$43.98 billion	394,749	1.38 million	Insider Trade
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
TAK Takeda Pharmaceutical	$13.17	22.71	$41.91 billion	968,360	1.83 million
CTSH Cognizant Technology Solutions	$79.49 +0.6%	17.59	$39.41 billion	917,247	3.73 million	Positive News
ARGX argenx	$629.99 +0.3%	N/A	$38.03 billion	151,737	307,383
IQV IQVIA	$199.99 +0.4%	26.25	$36.30 billion	398,015	1.20 million
VEEV Veeva Systems	$217.43 -3.3%	53.69	$35.30 billion	1.04 million	994,481
ALNY Alnylam Pharmaceuticals	$243.25 +0.4%	N/A	$31.37 billion	253,070	858,392
BNTX BioNTech	$114.13 +0.5%	N/A	$27.36 billion	131,794	805,492
ILMN Illumina	$135.21 +0.2%	N/A	$21.44 billion	527,972	2.05 million
LH Laboratory Co. of America	$229.49 +0.7%	44.39	$19.19 billion	144,095	656,923	Positive News
ICLR ICON Public	$213.26 +1.5%	23.77	$17.59 billion	453,758	761,085
UTHR United Therapeutics	$360.87 -0.8%	15.85	$16.11 billion	138,361	446,962	Positive News
MRNA Moderna	$40.27 +1.7%	N/A	$15.50 billion	2.52 million	5.13 million
RPRX Royalty Pharma	$25.23 -0.1%	13.07	$14.87 billion	1.35 million	2.70 million	Analyst Upgrade Positive News
RVTY Revvity	$112.34 +0.1%	54.27	$13.67 billion	214,093	845,786
SUZ Suzano	$10.11 +1.9%	16.05	$13.39 billion	948,044	1.83 million
PCVX Vaxcyte	$85.91 -1.3%	N/A	$10.71 billion	223,440	920,410
MEDP Medpace	$342.69 +1.1%	30.01	$10.65 billion	79,245	283,069
CRL Charles River Laboratories International	$186.29 +0.5%	23.32	$9.53 billion	231,454	617,372
BIO.B Bio-Rad Laboratories	$325.85	N/A	$9.12 billion	5	874	Positive News
FN Fabrinet	$221.24 +0.2%	26.18	$8.02 billion	185,948	497,093	Positive News
IBB iShares Biotechnology ETF	$133.95 +0.3%	N/A	$6.76 billion	462,833	1.46 million
LEGN Legend Biotech	$32.80 -3.3%	N/A	$5.99 billion	890,300	1.46 million
LITE Lumentum	$84.34 +1.3%	N/A	$5.79 billion	514,446	1.69 million
BE Bloom Energy	$24.33 +0.5%	N/A	$5.56 billion	1.70 million	6.56 million
TGTX TG Therapeutics	$32.16 -0.3%	N/A	$5.01 billion	496,456	3.56 million	Positive News
KRYS Krystal Biotech	$158.52 -1.4%	89.56	$4.71 billion	112,859	226,048
HTGC Hercules Capital	$19.59 +1.3%	9.70	$3.18 billion	270,631	945,989	News Coverage Positive News
DNLI Denali Therapeutics	$20.92 +0.7%	N/A	$3.01 billion	265,790	1.06 million
FOLD Amicus Therapeutics	$9.79 -0.5%	N/A	$2.93 billion	921,056	2.71 million
TWST Twist Bioscience	$48.90 +1.6%	N/A	$2.90 billion	221,995	942,512
SWTX SpringWorks Therapeutics	$36.81 -1.5%	N/A	$2.74 billion	286,225	1.00 million
VERA Vera Therapeutics	$41.92 -0.9%	N/A	$2.65 billion	158,565	871,051
ODD Oddity Tech	$44.67 +0.2%	27.24	$2.54 billion	150,874	646,482
DYN Dyne Therapeutics	$23.97 +0.3%	N/A	$2.44 billion	187,270	1.43 million	Positive News
Do this Before Elon’s Reveal on January 22nd (Ad) Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen. I urge you to watch this video now.
BEAM Beam Therapeutics	$28.81 +0.4%	N/A	$2.39 billion	263,588	1.23 million
SXI Standex International	$191.86 +1.5%	31.45	$2.32 billion	16,475	55,820
AZTA Azenta	$50.25 +0.4%	N/A	$2.30 billion	180,947	573,186
IOVA Iovance Biotherapeutics	$7.49 +0.4%	N/A	$2.28 billion	3.54 million	7.18 million
APGE Apogee Therapeutics	$47.32 -0.4%	N/A	$2.13 billion	168,076	501,633
RXRX Recursion Pharmaceuticals	$7.24 +3.6%	N/A	$2.08 billion	13.66 million	6.82 million	Options Volume Gap Up High Trading Volume
WVE Wave Life Sciences	$13.41 +2.2%	N/A	$2.05 billion	354,517	1.11 million
IBRX ImmunityBio	$2.63 -1.5%	N/A	$1.83 billion	2.02 million	5.05 million
GLPG Galapagos	$27.21 +0.4%	N/A	$1.79 billion	88,804	152,595
TXG 10x Genomics	$14.67 -0.4%	N/A	$1.78 billion	902,314	1.75 million
EVO Evotec	$5.00 +12.1%	N/A	$1.77 billion	279,794	140,198
FTRE Fortrea	$18.75 -0.1%	N/A	$1.68 billion	319,978	1.29 million
BCRX BioCryst Pharmaceuticals	$7.67 -1.4%	N/A	$1.59 billion	753,880	2.84 million
VRDN Viridian Therapeutics	$19.31 -1.8%	N/A	$1.53 billion	466,132	1.17 million
PHR Phreesia	$25.19 -0.7%	N/A	$1.46 billion	101,485	450,635
IMCR Immunocore	$28.66 +1.8%	N/A	$1.43 billion	148,988	497,696
NVAX Novavax	$8.51 -1.5%	N/A	$1.36 billion	1.48 million	9.16 million
ARVN Arvinas	$18.73 +4.1%	N/A	$1.29 billion	449,360	737,357
TPC Tutor Perini	$24.34 -2.8%	N/A	$1.28 billion	246,885	446,905	Analyst Downgrade
OCSL Oaktree Specialty Lending	$15.24 +1.7%	21.17	$1.25 billion	541,854	695,096
SYRE Spyre Therapeutics	$23.34 -1.1%	N/A	$1.20 billion	231,281	528,179
SEPN Septerna	$25.90 -4.4%	N/A	$1.15 billion	148,095	341,178
RCKT Rocket Pharmaceuticals	$11.68 +2.2%	N/A	$1.06 billion	701,101	844,111
UPB Upstream Bio	$19.40 +8.2%	N/A	$1.04 billion	162,844	363,669
VIR Vir Biotechnology	$7.38 +0.5%	N/A	$1.02 billion	413,977	1.08 million
RDW Redwire	$15.07 +7.2%	N/A	$1.00 billion	606,334	402,990
TRNS Transcat	$107.95 +2.6%	54.52	$993.03 million	24,367	55,202
ZYME Zymeworks	$14.14 -1.0%	N/A	$973.94 million	208,994	611,729
THR Thermon Group	$28.85 +0.8%	22.54	$971.81 million	123,870	195,295
ADPT Adaptive Biotechnologies	$6.39 +1.1%	N/A	$943.03 million	412,740	1.40 million
SLRC SLR Investment	$16.23 +0.6%	9.17	$885.43 million	107,424	160,380
COGT Cogent Biosciences	$7.86 +1.3%	N/A	$868.23 million	537,249	1.46 million
REPL Replimune Group	$12.50 +1.3%	N/A	$855.21 million	329,481	1.05 million
HQH Abrdn Healthcare Investors	$16.47 +0.8%	N/A	$833.79 million	186,854	167,964	News Coverage
PRTA Prothena	$15.40 +0.5%	N/A	$828.66 million	246,140	590,830
JTEK JPMorgan U.S. Tech Leaders ETF	$79.06 +1.5%	47.95	$804.83 million	52,668	77,144
CDMO Avid Bioservices	$12.26 -0.1%	N/A	$784.19 million	436,248	1.31 million
TCPC BlackRock TCP Capital	$8.67 +1.5%	N/A	$742.07 million	317,017	513,205	Positive News
WNC Wabash National	$17.12 +1.7%	N/A	$741.93 million	183,389	582,648	Positive News
TYRA Tyra Biosciences	$14.09 -1.1%	N/A	$713.00 million	58,694	195,821	Positive News
IMNM Immunome	$11.02 +0.5%	N/A	$687.84 million	594,254	784,188	Positive News
LAB Standard BioTools	$1.83 -2.1%	N/A	$681.23 million	309,864	2.39 million
DNTH Dianthus Therapeutics	$22.90 -1.2%	N/A	$677.77 million	189,057	205,539
RAPP Rapport Therapeutics	$18.46 +2.4%	N/A	$675.19 million	25,490	154,146
CRGX CARGO Therapeutics	$14.66 -0.4%	N/A	$674.77 million	74,655	259,206
TRDA Entrada Therapeutics	$17.56 +0.6%	11.04	$657.10 million	38,970	108,513
CAPR Capricor Therapeutics	$14.01 -0.8%	N/A	$637.04 million	333,817	1.20 million
GRAL Grail	$18.81 +0.5%	N/A	$632.04 million	289,458	1.09 million
SLP Simulations Plus	$28.35 +0.1%	57.86	$568.90 million	62,108	143,059	Positive News
TRML Tourmaline Bio	$21.40 +0.5%	N/A	$548.76 million	171,835	291,337	Positive News
Mysterious drone activity triggers massive 1,366% surge (Ad) If mysterious drones buzzing over the East Coast weren’t on your radar this year, you’re not alone. But here’s what you really need to know: An early warning signal tipped off investors to a tiny drone stock that later skyrocketed 1,366%. 👉 Click here now to see how this signal works.
DNA Ginkgo Bioworks	$9.37 -1.0%	N/A	$538.58 million	460,165	1.18 million
PROK ProKidney	$1.78 +5.3%	N/A	$519.16 million	382,621	686,996
OABI OmniAb	$3.53 +1.1%	N/A	$498.49 million	135,399	502,684
DDD 3D Systems	$3.56 +6.0%	N/A	$482.81 million	2.09 million	2.35 million
ABVX ABIVAX Société Anonyme	$7.60 +3.4%	N/A	$481.45 million	116,312	97,341	Positive News
PRTC PureTech Health	$19.92 -1.8%	N/A	$476.93 million	1,573	4,311
RNAC Cartesian Therapeutics	$18.47 -4.5%	N/A	$469.42 million	44,868	100,793	Gap Up
CELC Celcuity	$12.53 +1.0%	N/A	$465.24 million	160,045	281,133	News Coverage Positive News
TKNO Alpha Teknova	$8.60 +12.0%	N/A	$458.45 million	635,680	230,846	Gap Up High Trading Volume
MXCT MaxCyte	$4.11 +1.2%	N/A	$434.39 million	199,830	534,120

More Biotech Resources

For those interested in diving deeper into the biotech sector, here are a couple of valuable resources:

Biotech Stocks Frequently Asked Questions

Biotech stocks represent shares of companies in the biotechnology sector, which focuses on using biological processes, organisms, or systems to develop products that improve health, fight diseases, and benefit the environment. This sector includes companies that work on drug development, genetic research, biologically derived materials, and more. Due to the innovative and often breakthrough nature of their work, biotech stocks are known for their volatility but also for their potential to offer substantial returns.

Prominent players in the biotech sector include large, well-established companies such as Amgen, Gilead Sciences, and Biogen, which have multiple products on the market and solid research pipelines. Younger companies like Moderna and Regeneron are also notable, especially for their roles in developing treatments and vaccines at an accelerated pace in response to global health crises. These companies represent a mix of stable investments and high-growth potentials within the biotech industry.

While biotech exists in other areas, the majority of the biotech stocks are in the medical and agricultural sectors. Investors might choose individual stocks of companies they believe have potential based on their pipelines or existing products. However, due to the high risk associated with the biotech sector, many opt to diversify their exposure through biotech ETFs or mutual funds, which include a range of companies from startups to established leaders. This strategy can mitigate some of the risks while allowing investors to benefit from the sector's overall growth.

Before investing in biotech stocks, consider the unique risks of this sector, including high development costs, regulatory hurdles, and the binary nature of clinical trial results, which can dramatically affect a company's stock price. Investors should be prepared for volatility and have a tolerance for risk. It is also crucial to research and understand the specific focus areas of biotech companies, as these can vary widely from medical devices and pharmaceuticals to agricultural and environmental biotechnologies. Consulting with a financial advisor who understands the biotech sector can provide valuable insights and guidance tailored to your financial goals.

(Ad)

Commodities expert, Geof Smith, insists that the supercycle on gold is just getting warmed up. In fact, even though gold looks like this since he initially called a major bull run 11 months ago… He’s still predicting it will be the TOP trade of 2025. His free eBook explains why You see, the last time gold launched into a supercycle like this it surged 536% The time before that was over 1,000%... That’s why Geof released this urgent guide to help you. Most people think they’ve missed out, but he thinks we’re at the very beginning of what could be the largest gold rally of our lifetimes. But, believe it or not, Geof doesn’t think you should just buy and hold precious metals. He’ll share more about his approach inside the eBook and it might surprise you.

Top Biotech Stocks: Exploring Innovation Opportunities

Written by Jessica Mitacek | Reviewed by Don Miller

Updated June 6, 2024 | Reviewed on June 6, 2024

Biotech stocks continue to be a robust sector of the stock market. An aging population with increasing healthcare demands, combined with rapidly growing and improving technology, supports the growth of biotech stocks. The biotech industry is highly competitive and incredibly diverse, with a few companies managing to stand out and make a name for themselves.

Biotech stocks can be highly volatile, and some investors choose to diversify their exposure through biotech-focused exchange traded funds (ETFs) or mutual funds to mitigate some of the risks while allowing investors to benefit from the sector's overall growth. Some top ETFs tracking companies in the biotech sector are the SPDR S&P Biotech ETF (NYSEARCA: XBI), iShares Biotechnology ETF (NASDAQ : IBB), and ALPS Medical Breakthroughs ETF (NYSEARCA: SBIO).

Let’s take a look at some of the top biotech companies in the world.

Vertex Pharmaceuticals (NASDAQ: VRTX)

Vertex focuses on treatments for cystic fibrosis and has seen strong growth in recent years. The company ranks highly among biotech companies and is exploring gene editing as a treatment for muscular dystrophy and sickle cell anemia. Vertex’s rapid profit growth makes it an attractive investment.

Regeneron Pharmaceuticals (NASDAQ: REGN)

Regeneron has a robust pipeline of drugs, including successful treatments like EYLEA for eye diseases and Dupixent for autoimmune diseases, as well as promising candidates like odronextamab for follicular lymphoma. The company invests heavily in R&D, leading to breakthroughs in treatments for serious conditions, positioning it as a leader in the biotech industry.

Moderna (NASDAQ: MRNA)

Known for its COVID-19 vaccine, Moderna is developing new vaccines and treatments including a flu/COVID-19 combination vaccine expected by 2025 and an RSV vaccine candidate that could be approved soon. The company is investing heavily in mRNA technology for other vaccines and treatments.

Amgen (NASDAQ: AMGN)

As one of the largest biotech companies, Amgen has a diverse portfolio of drugs for various conditions. The company is valued at over $100 billion and offers a generous dividend yield, making it a stable investment.

BioMarin Pharmaceutical (NASDAQ: BMRN)

BioMarin focuses on rare diseases and gene therapies. Its significant products include Vimizim, Voxzogo, and Roctavian, which have shown substantial sales growth.

Gilead Sciences (NASDAQ: GILD)

A leader in both HIV and liver diseases, Gildead is known for its revolutionary treatment for Hepatitis C released in 2014. The company has a strong pipeline with promising therapies in development, particularly in oncology and virology, which are expected to drive future growth. Gilead has also made strategic acquisitions to bolster its R&D capabilities and expand its market presence.

Legend Biotech (NASDAQ: LEGN)

This clinical-stage biopharma company specializes in cell therapies for cancer. Its breakthrough CAR-T cell therapy, Carvykti, has shown significant efficacy in treating multiple myeloma. In addition, the company has collaborated with Johnson & Johnson’s Janssen unit.

About The Editor

Jessica Mitacek

Associate Editor & Contributing Author

Market Analysis and Research

Learn More

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Best Biotechnology Stocks

More Biotech Resources

Biotech Stocks Frequently Asked Questions

Top Biotech Stocks: Exploring Innovation Opportunities

Jessica Mitacek

Associate Editor & Contributing Author

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Best Biotechnology Stocks

More Biotech Resources

Biotech Stocks Frequently Asked Questions

What Are Biotech Stocks?

What Are the Leading Companies in the Biotech Sector?

How Can I Invest in Biotech Stocks?

What Should I Consider Before Investing in Biotech Stocks?

Top Biotech Stocks: Exploring Innovation Opportunities

Jessica Mitacek

Associate Editor & Contributing Author

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools